Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 2/20 | 0.52 |
| ▸ | GRM8 | O00222 | 2/20 | 0.52 |
| ▸ | GRM6 | O15303 | 2/20 | 0.52 |
| ▸ | GRM7 | Q14831 | 2/20 | 0.52 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.52 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.52 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.52 |
| ▸ | GRM5 | P41594 | 1/20 | 0.52 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.52 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.52 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.52 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.52 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.52 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.52 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.52 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.52 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.52 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 6-Diazo-5-Oxo-L-Norleucine SCHEMBL4281654 | 1.00 | GSR (0.52) | GSRGRM8GRM6GRM7GRM4 | |
| 6-Diazo-5-Oxo-L-Norleucine SCHEMBL295053 | 1.00 | GSR (0.52) | GSRGRM8GRM6GRM7GRM4 | |
| SCHEMBL3052694 | 0.89 | GSR (0.46) | GSRGRM8GRM6GRM7GRM4 | |
| 6-Diazo-5-Oxo-L-Norleucine SCHEMBL8937857 | 0.82 | GRM8 (0.36) | GSRGRM8GRM6GRM7GRM4 | |
| SCHEMBL17918640 | 0.81 | GRM8 (0.52) | GSRGRM8GRM6GRM7GRM4 | |
| Azotomycin SCHEMBL8614187 | 0.81 | NOD1 (0.49) | — | |
| SCHEMBL4078048 | 0.80 | GRIK1 (0.44) | GRIK1GRIA1GRIA2SLC1A3SLC1A2 | |
| SCHEMBL4078056 | 0.80 | GRIK1 (0.44) | GRIK1GRIA1GRIA2SLC1A3SLC1A2 | |
| SCHEMBL28748529 | 0.79 | LTA4H (0.36) | CYP1A2SLC1A1ALDH1A1 | |
| SCHEMBL18476646 | 0.78 | FAAH (0.38) | CYP1A2ALOX15ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 23188 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748859-A2 | CHEMICALLY AND PHOTOCHEMICALLY INITIATED CELL MEMBRANE BLEBBING TO INDUCE CELL VESICLE PRODUCTION, MODIFICATIONS THEREOF, AND USES THEREOF | The Regents of the University of California (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4743490-A1 | HUMANIZED ANTI-CD7 ANTIBODY | Christian-Albrechts-Universität zu Kiel (DE) | 2026-05-20 | — | — | EP | claimed |
| WO-2026099502-A1 | NOVEL DRUG CONJUGATES FOR TESTING CELLULAR DRUG UPTAKE | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2026-05-15 | — | — | WO | claimed |
| CN-122010771-A | 6-Diazonium-5-oxo-norleucine derivative, preparation method and application | 西北工业大学深圳研究院 | 2026-05-12 | — | — | CN | claimed |
| US-20260115305-A1 | LINKERS, CONJUGATES AND APPLICATIONS THEREOF | GENEQUANTUM HEALTHCARE SUZHOU CO LTD (CN) | 2026-04-30 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| US-20260085100-A1 | METHODS OF ANTIGEN PRODUCTION | THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY (US) | 2026-03-26 | — | — | US | claimed |
| US-20260077056-A1 | LINKER-PAYLOAD COMPOUND, CONJUGATES AND APPLICATIONS THEREOF | GENEQUANTUM HEALTHCARE SUZHOU CO LTD (CN) | 2026-03-19 | — | — | US | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| EP-4698185-A1 | METHODS AND SYSTEMS FOR IMPROVING ANTI-CANCER THERAPIES | Osasuna Therapeutics SA (CH) | 2026-02-25 | — | — | EP | claimed |
| US-5756650-A | COMPOSITION COMPRISING POLYAMIC ACID, CURE ACCELERATOR SELECTED FROM GROUP CONSISTING OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, AMINO ACID COMPOUND, AROMATIC COMPOUND HAVING TWO OR MORE HYDROXYL GROUPS | KABUSHIKI KAISHA TOSHIBA (JP) | 1998-05-26 | — | — | US | claimed |
| US-5695751-A | ADMINISTERING L-AMINO ACID OXIDASE TO REDUCE PLASMA LEVEL OF LARGE AMINO ACIDS TO ALLOW INCREASED TRANSPORT OF LARGE AMINO ACID DRUGS ACROSS BLOOD BRAIN BARRIER | CORNELL RESEARCH FOUNDATION, INC. (US) | 1997-12-09 | — | — | US | claimed |
| EP-0532219-B1 | Cosmetic composition | UNILEVER PLC (GB) | 1996-05-08 | — | — | EP | claimed |
| EP-0641193-A4 | CHEMOTHERAPEUTIC DRUG COMBINATIONS. | MARTIN DANIEL S (US) | 1995-09-06 | — | — | EP | claimed |
| EP-0641193-A1 | CHEMOTHERAPEUTIC DRUG COMBINATIONS | PRO-NEURON, INC. (US) | 1995-03-08 | — | — | EP | claimed |
| US-5378455-A | Glutamine metabolism inhibitors using enzymes | CHESEBROUGH-PONDS USA CO., DIVISION OF CONOPCO, INC. (US) | 1995-01-03 | — | — | US | claimed |
| WO-1993023014-A1 | CHEMOTHERAPEUTIC DRUG COMBINATIONS | MARTIN DANIEL S (US) | 1993-11-25 | — | — | WO | claimed |
| EP-0532219-A2 | Cosmetic composition | UNILEVER PLC (GB) | 1993-03-17 | — | — | EP | claimed |
| EP-0140556-B1 | A T-DNA DERIVED VECTOR | LUBRIZOL GENETICS INC. (US) | 1992-07-15 | — | — | EP | claimed |
| EP-0140556-A1 | A T-DNA derived vector | LUBRIZOL GENETICS INC. (US) | 1985-05-08 | — | — | EP | claimed |